Method Development and Validation for Particle Size and Shape Measurements



Similar documents
VALIDATION OF WET AND DRY LASER DIFFRACTION PARTICLE CHARACTERISATION METHODS.

LIFE SCIENCE I TECHNICAL BULLETIN ISSUE N 11 /JULY 2008

Particle size measurement of lactose for dry powder inhalers

Setting Size Specifications

PARTICLE SIZE. By: Philo Morse, MS, and Andrew Loxley, PhD. INTRODUCTION are not as stringent as for scattering techniques.

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

DYNAMIC LIGHT SCATTERING COMMON TERMS DEFINED

ANALYTICAL METHODS INTERNATIONAL QUALITY SYSTEMS

Implementing New USP Chapters for Analytical Method Validation

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

Guidance for Industry

Molysulfide. Particle Size Analysis

The Basic Principles of Sieve Analysis

VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1)

Particle Size Analysis

Revision of The Dissolution Procedure: Development and Validation 1092

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

Pharmaceutical Quality Systems: US Perspective

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

Validation and Calibration. Definitions and Terminology

IN-LINE PARTICLE SIZE MEASUREMENTS FOR CEMENT AND OTHER ABRASIVE PROCESS ENVIRONMENTS

Particle Surface Area

PROCESS PARTICLE COUNTER (PPC) SENSOR/CONTROLLER FOR OPTIMIZING POWER RECOVERY EXPANDER AND GAS TURBINE PERFORMANCE

Content Uniformity (CU) testing for the 21 st Century: CDER Perspective

Analytical Methods for Cleaning Validation

Guidance for Industry

Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011

Applying Statistics Recommended by Regulatory Documents

UNIVERSITY OF PARMA INTERDEPARTMENTAL CENTRE FOR INNOVATION IN HEALTH PRODUCTS, BIOPHARMANET-TEC

ISO A Standard Methodology to Optical Particle Counter Calibration and What It Means to Cleanroom Owners

GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.

Lifecycle Management of Analytical Procedures; What is it all about? Jane Weitzel Independent Consultant

POWDER PROPERTIES LABORATORY

Scanning Electron Microscopy Services for Pharmaceutical Manufacturers

The importance of normalisation when comparing tablet properties

Operating Principle of the Sample Positioning Flaps

IVHHN GUIDELINES FOR GRAIN-SIZE DISTRIBUTION ANALYSIS

EUDRAGIT E 100, EUDRAGIT E PO and

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Sampling. References: Introduction: Methods of Sampling from a Conveyor Belt:

Reversed Phase High Presssure Liquid Chromatograhphic Technique for Determination of Sodium Alginate from Oral Suspension

IUCLID 5 COMPOSITION AND ANALYSIS GUIDANCE DOCUMENT: IRON ORES, AGGLOMERATES [EINECS NUMBER , CAS NUMBER ] IRON ORE PELLETS

QbD Considerations for Analytical Methods - FDA Perspective

Solid dosage forms testing: Disintegration test and tablet friability and hardness

Bioequivalence Testing, using the Dissolution Profile

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

Validating Methods using Waters Empower TM 2 Method. Validation. Manager

Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval Issues as per USFDA

A New Technique Provides Faster Particle Size Analysis at a Lower Cost Compared to Conventional Methods

Improving the consistency of particle size measurement. Improving the consistency of particle size measurement

Is This Combustible Dust?

Radial-axial Radial mixing is based on the premise that the fluids to be mixed enter the mixer in the correct proportions simultaneously

It is an important tool to assess factors that affect the bioavailability of a drug from a solid preparartion.

2.3 QUALITY OVERALL SUMMARY Sakura Tablet

Top and Bottom Spray Fluid Bed Granulation Process

Design of Experiments for Analytical Method Development and Validation

PARTICLE SIZES EXPLAINED

Annex 7 Guidelines on pre-approval inspections

A.17. OXIDIZING PROPERTIES (SOLIDS)

Particle size. Integrated systems for particle sizing. detailed specification sheets from

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011

ENVIRONMENTAL MONITORING / TESTING TO CONFORM WITH ISO14644 & TGA GMP REQUIREMENTS

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

European Continuing Education College

GUIDANCE DOCUMENT ON THE DETERMINATION OF PARTICLE SIZE DISTRIBUTION, FIBRE LENGTH AND DIAMETER DISTRIBUTION OF CHEMICAL SUBSTANCES

Lapping and Polishing Basics

Develop a Quantitative Analytical Method for low (» 1 ppm) levels of Sulfate

FAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

Evaluating System Suitability CE, GC, LC and A/D ChemStation Revisions: A.03.0x- A.08.0x

ZETA POTENTIAL ANALYSIS OF NANOPARTICLES

The Story of Magnesium Stearate as a Powder and a Tablet Lubricant

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Assay Development and Method Validation Essentials

Standard Test Procedures Manual

Regulations Concerning

Guideline on Process Validation

Working with ICH Quality Guidelines - the Canadian Perspective

How To Test For Contamination In Large Volume Water

NOTE: FOR PROJECTS REQUIRING CONTRACTOR MIX DESIGN, THE DESIGN PROCEDURES ARE SPECIFIED IN THE SPECIAL PROVISIONS OF THE CONTRACT.

PHARMACEUTICAL DEVELOPMENT

Mapei, Italy Economic benefits of standards Case Study. September 2011 June 2012

ICH Topic Q 6 A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances.

A GUIDEBOOK TO PARTICLE SIZE ANALYSIS

Redefining Spray Technology

ERDOSTEINE - MONOGRAPH.

Performance and advantages of qnmr measurements

Overview of Pre-Approval Inspections

Chapter 8 Design of Concrete Mixes

LC-MS/MS Method for the Determination of Docetaxel in Human Serum for Clinical Research

GUIDELINES FOR TESTING FRESH SELF-COMPACTING CONCRETE

ICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology. Step 5

Evaluation of Dissolution Hydrodynamics in the USP, Peak and Flat-Bottom Vessels Using Different Solubility Drugs

<788> PARTICULATE MATTER IN INJECTIONS

Technical Data. 7. Bearing Fits. 7.1 Interference. 7.2 Calculation of interference F B LLLLLLLLL( A-54

Gas Custody Transfer Calibration

Bundesinstitut für Arzneimittel und Medizinprodukte. Dissolution Testing. Analytik,Methodenentwicklung, Bioäquivalenz SAQ. Olten, 25.

Reference Materials for Environmental Performance Testing Dr Steve Wood Head of Regulatory and Legislative Services. ISPRA 25 June 2009

Transcription:

Method Development and Validation for Particle Size and Shape Measurements Ulf Willén Divisional Product Manager Analytical Imaging Systems Malvern Instruments Ltd, Malvern, UK.

FDA guidance: when should particle size be measured? International Conference on Harmonization; Guidance on Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances* 3.3.1 New Drug Substances (b) Particle size: For some new drug substances intended for use in solid or suspension drug products, particle size can have a significant effect on dissolution rates, bioavailability, and/or stability. In such instances, testing for particle size distribution should be carried out using an appropriate procedure, and acceptance criteria should be provided. Decision Tree #3 provides additional guidance on when particle size testing should be considered. *Federal Register/Vol. 65, No.251, Friday December 29, 2000/ Notices p. 83041-83054

FDA guidance: when should particle size be measured? Yes to any? Solid dosage form or liquid with undissolved drug? Yes Critical to dissolution, solubility, bioavailability? Set acceptance criterion No No drug substance particle size criterion required for solution dosage forms Critical to drug product processability? Critical to product stability? No to all? Critical to product content uniformity? No acceptance criterion necessary

Comparing techniques: assessing different technologies

Comparing techniques: assessing different technologies

Better Characterisation - Size and Shape Size Only % % Size Large Primary Particles Size Aggregates (Low circularity) Size and Shape Circularity Circularity Size Size

Convexity - Dissolution behaviour Lower convexity higher surface area Increased surface area faster dissolution

Laser Diffraction & Optical Imaging Optical Microscopy (USP <776>, ISO 13322-1) Laser Diffraction (USP <429>, EP 2.9.31, ISO13320-1)

What information should be included in the particle size specification? ICH Q6A Guidance Analytical Procedure (system suitability, sampling, dispersion,, etc.) Method Validation (precision, ruggedness, dispersion stability, robustness, etc.) Acceptance Criteria (upper and lower limits)

FDA guidance: Analytical Procedures and Methods Validation* The normal concepts of validation may differ for particle size methodologies as compared to other analytical methodologies such as HPLC. the system should be calibrated according to the manufacturers and/or the laboratory s specification, as appropriate. The methods validation usually involves evaluation of intermediate precision and robustness. Assurance should be provided that the data generated are reproducible and control the product s quality. *Section F: Methodologies relating to particle size analysis;

Professor Harold Heywood (1905-1971) However, it must be realised that particle size analysis is not an objective in itself but is a means to an end, the end being the correlation of powder properties with some process of manufacture, usage or preparation H Heywood Proc. 1st Particle Size Anal. Conf. September 1966 p 355-359 (Heffer)

FDA guidance: why should accuracy not be assessed? Accuracy can be difficult to define for size analysis Easy for spherical particles For non-spherical particles all sizing techniques give different answers. For laser diffraction: You do need to verify the system See ISO13320 / USP<429> / EP 2.9.31 for details Microscopy is the most important referee method

Method development and validation: PASG definition of sample preparation* The pre-treatment and the presentation of the sample to the measuring technique in a meaningful manner. Need to consider How the primary sample is obtained How the material is dispersed Wet or dry dispersion? Dispersed or agglomerated state? *See Bell, R., Dennis, A., Henriksen, B., North, N., and Sherwood, J., (1999) Position Paper on Particle Sizing: Sample Preparation, Method Validation and Data Presentation Pharmaceutical Technology Europe, November

Sample presentation: what do we need to consider? Novices in the size measurement field must understand that most errors in size measurement arise through poor sampling and dispersion and not through instrument inadequacies. T. Allen, Advances in Ceramics, Vol 21: Ceramic Powder Science, page 721, The American Ceramic Society Inc. (1987) Dr. Henk Merkus Quality Assurance in Particle Size Measurement from Improving Standards in Particle Size Distribution Measurement, February 17-19, 1997, at the Engineering Research Centre for Particle Science and Technology

Sampling: particle segregation

Sampling: typical errors associated with different techniques Method Cone & Quartering Scoop Sampling Table Sampling Chute Riffler Spinning Riffler Estimated max error (%) 22.7 17.1 7.0 3.4 0.42 From: T. Allen Particle Size Measurement Chapman and Hall 4th Edition 1993 Page 39. Figures based on a 60:40 sand mixture.

Sampling: using a spinning riffler Sample stream from a vibrating hopper Sample pots on a revolving tray

Sampling: riffled sample measurements 350 300 RSDs Size / Microns 250 200 150 Dv10 Dv50 Dv90 Dv10: 2.8% Dv50: 2.9% Dv90: 1.4% 100 50 0 0 2 4 6 8 10 12 14 16 18 20 Measurement Number

Sampling: obtaining unbiased samples from slurry systems Stirrer Isokinetic sampling probe Flow baffles Speed of sample rise matches sample extraction velocity

Sample preparation: product form

Sample presentation: force of adhesion / cohesion between particles 10 7 10 6 Force of Adhesion / Gravitational Force 10 5 10 4 10 3 10 2 10 1 10 0 10-1 10-2 10-3 10-4 Adhesion 10-5 0.01 0.1 1 10 100 1000 10000 Particle Size / Microns From: Aerosol Science, Ed. C N Davies, Academic Press, London and New York, 1966

Sample presentation: affect of sonication on the particle size reported by laser diffraction 250 Initial Dispersion (Pump and Stirrer) Ultrasound Applied Ultrasound Off Particle Size / Microns 200 150 100 Dv10 Dv50 Dv90 50 0 0 5 10 15 20 Measurement Number

Using image analysis as a referee method After inappropriate level of sonication broken particles With reduced level of sonication no broken particles

Using image analysis as a referee method Pharmaceutical dispersed in cyclohexane With no surfactant a high level of agglomeration is observed Wide size and shape distributions Images show high degree of agglomeration

Using image analysis as a referee method Same sample but with addition of lecithin Narrower and smoother size and shape distributions Images confirm individual particles and little agglomeration

Sample presentation: changes in size as a function of pressure 80 60 Dv10 Dv50 Dv90 Size / Microns 40 20 0 0 1 2 3 4 Dispersion Pressure / bar

Sample presentation: changes in size as a function of pressure microscopy as a referee technique High Pressure Increased proportion of fines less large material Low Pressure More large material fewer fines

Sample presentation: changes in size as a function of pressure microscopy as a referee technique Pressure titration against Particle Size and Aspect ratio Trend Graph CE Diameter Mean (µm) 70 69 68 67 66 65 64 63 62 61 60 Increased pressure = Increased Aspect Ratio 0.62 0.61 0.60 0.59 Aspect Ratio Mean 59 0.58 58 57 Increased pressure = reduced Size 56 0.57 0 1 2 3 4 injectionpressure CE Diameter Mean (µm) Aspect Ratio Mean

Sample presentation: changes in size as a function of pressure microscopy as a referee technique Low pressure dispersion example images of largest particles long, low aspect ratio (needle like) High pressure dispersion example images of largest particles - short, high aspect ratio.

Using image analysis as a referee method Dv10 / Microns Dv50 / Microns Dv90 / Microns Dv10 / Microns Dv50 / Microns Dv90 / Microns Mastersizer 2000 1.03 2.31 5.00 Mastersizer 2000 2.0 5.1 12.7 Morphologi G3 1.44 2.66 5.30 Morphologi G3 2.7 6.5 12.7

Sample presentation: using image analysis as a referee method 8 Mastersizer 2000 Volume (%) 6 4 2 0 1 10 100 1000 Particle Size / Microns

Sample presentation: using image analysis as a referee method 50 40 Morphologi G3 CE diameter Morphologi G3 length Morphologi G3 width Mastersizer 2000 Volume (%) 30 20 10 0 1 10 100 1000 Particle Size / Microns USP<792>: For irregularly shaped particles, characterisation of particle size must include information on particle shape.

Using image analysis as a referee method : verifying optical properties 12 Initial Result (RI = 1.53) 10 Volume (%) 8 6 4 2 0 1 10 100 1000 Particle Size / μm

Comparing imaging and diffraction: verifying optical properties 12 10 Final Result (RI = 1.345) Volume (%) 8 6 4 2 0 1 10 100 1000 Particle Size / μm

Method development: available guidance for laser diffraction measurements ISO13320-1: Section 6.4 Dv50-5 different readings: COV < 3% Dv10 and Dv90: COV < 5% Below 10μm, these maximum values should be doubled. USP <429> Provides reproducibility ranges Dv50 or any central value: <10% Dv10, Dv90 or any non-central value: <15% Below 10μm, these maximum values should be doubled. EP 2.9.31 provides similar advice to USP<429>

Method validation: precision for excipient measurements using laser diffraction Sample Number Dv10 / μm Dv50 / μm Dv90 / μm 1 1.22 23.68 63.23 2 1.17 23.77 60.02 3 1.09 22.79 56.59 4 1.16 23.63 62.55 5 1.11 22.26 59.68 6 1.18 22.78 65.36 7 1.12 23.41 61.47 Mean 1.15 23.19 61.27 COV (%) 3.95 2.50 4.63 Measurements of multiple samples (n 6) by a single operator RSD within USP <429> and ISO13320 limits for laser diffraction variation in Dv10 due to dispersion variation in Dv90 due to sampling Scoop sampling used in this case.

Method validation: intermediate precision for excipient measurements using laser diffraction Sample Number Dv10 / μm Dv50 / μm Dv90 / μm 1 1.06 22.92 61.01 2 1.08 22.08 56.54 3 1.04 21.66 62.17 4 0.97 22.55 60.23 5 1.04 22.74 57.98 6 0.99 23.58 59.86 7 0.95 22.11 62.78 Mean 1.02 22.52 60.08 COV (%) 4.79 2.83 3.69 Parameter Pooled Value Mean Dv50 / μm 22.85 Standard Deviation 0.68 COV (%) 2.98 Pooled RSD for both analysts is within the USP<429> and ISO13320 limits.

Method validation: reproducibility Should now go on to test reproducibility Defined as the precision between laboratories* Modern sizing systems can store and replay measurement procedures method files can then be emailed to other sites Main challenge is related to the control of the laboratory conditions and dispersant quality *See Bell, R., Dennis, A., Henriksen, B., North, N., and Sherwood, J., (1999) Position Paper on Particle Sizing: Sample Preparation, Method Validation and data Presentation Pharmaceutical Technology Europe, November

Microscopy - how many particles do I need to measure? ISO 13322-1 Particle size analysis Image analysis methods Part1: Static image analysis methods - proposes a method to evaluate minimum number of particles to achieve certain confidence of mass median diameter (Dv50) being within a certain statistical error Maths can be reduced to one input: standard deviation Example: Sample with GSD of 1.6 needs 61,000 particles to achieve mass median diameter within 5% error with 95% probability

Using image analysis as a referee method

Morphologi G3 Automated Particle Image Analyser

Mixture of API and Starch Volume transformation: CE Diameter (µm) smoothed over 50 points 0.8 0.7 0.6 0.5 % 0.4 0.3 0.2 0.1 0.0 0.1 1 10 100 1000 10000 CE Diameter (µm) Record 2: API Starch 1 classed

Mixture of API and Starch Starch - only High circularity Low elongation

Mixture of API and Starch API - only High elongation Low circularity

Mixture of API and Starch CE Diam. (vol) for Mixture, API(39%) and Starch (61%) Volume transformation: CE Diameter (µm) smoothed over 50 points 1.1 1.0 0.9 0.8 0.7 0.6 % 0.5 0.4 0.3 0.2 0.1 0.0 0.1 1 10 100 1000 10000 CE Diameter (µm) Record 2: API Starch 1 classed Record 9: API Starch 1 classed - API Record 10: API Starch 1 classed -Starch

Conclusions Need to consider the Precision, Intermediate Precision and Robustness of measurements during method development and validation Requires an understanding of how the sampling and dispersion is achieved Need to ensure that the sample preparation method is reasonable in terms of predicting the properties of the product being tested Remember to look for specific guidance relating to the expected precision of the measurements

Where can I find out more? www.malvern.com Product information Application Notes Live Webinars On-demand Presentations Useful Links